Haymarket Medical has taken over the operations of two US
HealthCare Communications oncology titles—The American Journal of
Hematology/Oncology and Oncology Nursing News.
Haymarket Medical's parent company owns MM&M. Terms of
the deal were not disclosed.
Haymarket brought on two execs from Quadrant HealthCom to
run it. Steven Svec, who was VP/group publisher at Quadrant, will serve as
publisher of the titles, and Chad Holloway, an associate publisher at Quadrant,
will serve as sales director.
The American Journal of Hematology/Oncology remains a
monthly, with a circulation of around 40,000 oncologists, hematology-oncologists
and sub-specialists, and will continue to be based in San Diego. Oncology
Nursing News will go down to a bimonthly schedule, with a circulation of around
29,000, and will be moved into Haymarket's New York offices.
Haymarket Medical CEO Lee
Maniscalco said: “The practical, clinical guidance these peer-reviewed
publications offer to their readers and the wide variety of continuing
education opportunities they provide throughout the year make this a perfect
fit for Haymarket.” It's easy to see why Haymarket wants to play in the
oncology space. The category was a rare bright spot in a bleak year for medical
journals last year, with cancer therapies, the seventh-most heavily advertised
area according to PERQ/HCI.